Cadrenal Therapeutics, Inc. (CVKD) KPIs and segments
CVKDNasdaqPharmaceutical PreparationsFiscal year ends December 31
$1.88+0.48 (+34.29%)
Close on Nov 17, 2026Market cap $6.71MP/E –Yield 877.66%
KPIs & segments
Operating metrics and segments that drive Cadrenal Therapeutics's business
Coming soon
This tab will track the numbers specific to Cadrenal Therapeutics's business model — such as store count, revenue by banner, revenue per store and new openings — taken from filings and earnings releases.
See a number that looks wrong?